Europe PTA Balloon Catheter Market

Europe PTA Balloon Catheter Market Size (2023 to 2028)

The PTA balloon catheter market size in Europe is expected to be valued at USD 0.73 billion by 2028 from USD 0.51 billion in 2023, growing at a CAGR of 7.39% from 2023 to 2028.

The rising prevalence of cardiovascular diseases and the growing geriatric population across Europe primarily drive the growth of the Europe PTA balloon catheter market. With cardiovascular disease accounting for a significant percentage of deaths in Europe, factors such as unhealthy lifestyle choices, high sugar consumption, and smoking contribute to the rise in heart-related ailments. Cardiovascular diseases encompass a range of conditions, including thrombosis, atherosclerosis, coronary heart disease, stroke, peripheral arterial disease and aortic disease. The growing cases of diabetes and obesity in the region. PTA balloon catheter products play a crucial role in the treatment of these cardiovascular conditions boosting the market growth in the European region.

The growing adoption of minimally invasive surgery, specifically percutaneous transluminal angioplasty, contributes to the growing demand for PTA balloon catheters in Europe and drives the European market growth. This surgical procedure involves the use of a small, flexible plastic tube with a balloon at the end to open blocked blood vessels. By placing the tube in the affected artery or blood vessel, normal blood flow can be restored. The benefits of minimal invasion surgery, including reduced pain, shorter hospital stays, and smaller incisions, have led to its widespread adoption among patients. Consequently, the demand for PTA balloon catheters has risen as these devices play a crucial role in enabling successful minimally invasive procedures.

The continual advancements in PTA balloon catheter products and devices fuel the European market growth. Manufacturers and researchers prioritize the development of high-quality and cost-effective devices to enhance surgical outcomes and reduce overall procedure costs. The growing investments by healthcare companies, improved infrastructure in research centers and a rising number of product approvals contribute to the growth of the European market.

The high cost of the procedure, limited availability of balloon catheter sizes and a shortage of skilled healthcare providers in Europe majorly hamper the growth of the PTA balloon catheter market in Europe. The lack of awareness about the benefits of PTA balloon catheter procedures inhibits the European market growth. Risks and complications, such as bleeding at the catheter insertion site and potential damage to blood vessels further impede the growth of the European market.

This research report on the Europe PTA balloon catheter market has been segmented and sub-segmented into the following categories.

By Material Type:

• Polyurethane
• Nylon

By Application:

• Coronary Artery Disease
• Peripheral Vascular Disease

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Europe held the second biggest share of the global market in 2022 and is anticipated to grow at a healthy growth rate during the forecast period. Germany is expected to hold the leading share of the European market during the forecast period among all the countries of Europe. The presence of specialized hospitals for cardiac diseases, increasing healthcare expenditure by the German population and the measures and regulations of the German government for the approval of novel PTA balloon catheters to reduce complications during cardiac surgeries drive the German market growth. The robust manufacturing facilities and a growing number of clinical trials in Germany further fuel the German market growth. Manufacturers in Germany are focused on developing customized and personalized balloon catheters, facilitating smoother treatment procedures for healthcare providers. The UK is estimated to witness a healthy CAGR during the forecast period owing to the growing investment by healthcare organizations in the establishment of specialized centers for PTA balloon catheter surgeries. The growing number of mergers, partnerships and rising demand for balloon catheters to address diverse medical conditions further propel the UK market growth.

KEY MARKET PLAYERS:

Companies that dominate the Europe PTA balloon catheter market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, B. Braun Melsungen AG and Cook Medical Inc.